S
Shape Biopharmaceuticals develops next‑generation immunotherapies for chronic diseases with high unmet needs. It uses computational epitope‑specific antigen design and protein engineering to optimize antigen properties, and delivers them via tailored nanoparticle formulations. The platform aims to generate personalized therapeutic antibodies directly in patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Shape Biopharmaceuticals develops next‑generation immunotherapies for chronic diseases with high unmet needs. It uses computational epitope‑specific antigen design and protein engineering to optimize antigen properties, and delivers them via tailored nanoparticle formulations. The platform aims to generate personalized therapeutic antibodies directly in patients.